Novi primarni zloćudni tumori nakon dijagnoze raka dojke: međuodnos naslijeđa, rizičnih čimbenika i modaliteta liječenja [New primary malignancies after breast cancer diagnosis: interplay of genetics, risk factors and treatment modalities].

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-02-27

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Germline RAD51C mutations in ovarian cancer susceptibility

  2013cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

  2012cited by this paper
• Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature

  2012cited by this paper
• Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.

  2012cited by this paper
• Twenty-five year results of the national cancer institute randomized breast conservation trial

  2012cited by this paper
• The role of BRCA1 and BRCA2 in prostate cancer.

  2012cited by this paper
• Exemestane for breast-cancer prevention in postmenopausal women.

  2011cited by this paper
• Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen.

  2011cited by this paper
• The cancer burden in the United Kingdom in 2007 due to radiotherapy

  2011cited by this paper
• Current role and safety profile of aromatase inhibitors in early breast cancer

  2011cited by this paper
• Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review

  2011cited by this paper
• Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.

  2011cited by this paper
• Rates of second malignancies after definitive local treatment for ductal carcinoma in situ of the breast.

  2011cited by this paper
• Mediterranean Journal of Hematology and Infectious Diseases Incidence of Acute Myeloid Leukemia after Epidemiology and Mortality of Breast Cancer Incidence of Acute Myeloid Leukemia after Breast Cancer Mediterranean Journal of Hematology and Infectious Diseases Role of Adjuvant Chemotherapy. Adjuvan

  2011cited by this paper
• Overview of long term care of breast cancer survivors.

  2011cited by this paper
• Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy

  2011cited by this paper
• Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity

  2011cited by this paper
• Risk for second primary non-breast cancer in pre- and postmenopausal women with breast cancer not treated with chemotherapy, radiotherapy or endocrine therapy.

  2011cited by this paper
• Fulvestrant

  2011cited by this paper
• Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.

  2010cited by this paper
• [Tamoxifen and endometrial pathology].

  2010cited by this paper
• Second solid cancers after radiotherapy for breast cancer in SEER cancer registries

  2009cited by this paper
• Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.

  2009cited by this paper
• Nonbreast second malignancies after treatment of primary breast cancer.

  2009cited by this paper
• Effects of tamoxifen on the cervix and uterus in women with breast cancer: experience with Iranian patients and a literature review.

  2009cited by this paper
• A Prediction Study on Radiation-induced Second Malignancies for IMRT Treatment Delivery

  2009cited by this paper
• Incidence of multiple primary malignancies in women diagnosed with breast cancer.

  2009cited by this paper
• Early breast cancer.

  2009cited by this paper
• Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan

  2008cited by this paper
• Second malignancies after breast cancer: the impact of different treatment modalities

  2008cited by this paper
• Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.

  2008cited by this paper
• Risk of second non-hematological malignancies among 376,825 breast cancer survivors

  2007cited by this paper
• Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials

  2007cited by this paper
• New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000.

  2006cited by this paper
• Risk of second cancer among women with breast cancer

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD,

  2006cited by this paper
• Increased risk of second malignancies after in situ breast carcinoma in a population-based registry

  2006cited by this paper
• Effect of screening and adjuvant therapy on mortality from breast cancer

  2005cited by this paper
• Association between female breast cancer and cutaneous melanoma

  2004cited by this paper
• Radiation-induced malignancies following radiotherapy for breast cancer

  2004cited by this paper
• Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment

  2003cited by this paper
• Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients.

  2003cited by this paper
• Increased risk of second cancers following breast cancer: Role of the initial treatment

  2000cited by this paper
• High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma Families

  2000cited by this paper
• Second cancers after adjuvant tamoxifen therapy for breast cancer.

  1996cited by this paper
• Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens.

  1985cited by this paper

• No citing papers are available for this paper.